Literature DB >> 28291404

Outcomes and effectiveness of posterior occipitocervical fusion for suboccipital spinal metastases.

Panya Luksanapruksa1, Jacob M Buchowski2, Neill M Wright3, Frank H Valone2, Colleen Peters2, David B Bumpass4.   

Abstract

OBJECTIVE The incidence of suboccipital spinal metastases is rare but has increased given cancer patients' longer life expectancies. Operative treatment in this region is often challenging because of limited fixation points due to tumor lysis, as well as adjacent neural and vascular anatomy. Few studies have reported on this population of cancer patients. The purpose of this study was to evaluate clinical outcomes and complications of patients with suboccipital spinal metastases who had undergone posterior occipitocervical fixation. METHODS A single-institution database was reviewed to identify patients with suboccipital metastases who had undergone posterior-only instrumented fusion between 1999 and 2014. Clinical presentation, perioperative complications, and postoperative results were analyzed. Pain was assessed using the visual analog scale. Survival analysis was performed using a Kaplan-Meier curve. The revised Tokuhashi and the Tomita scoring systems were used for prognosis prediction. RESULTS Fifteen patients were identified, 10 men and 5 women with mean age of 64.8 ± 11.8 years (range 48-80 years). Severe neck pain without neurological deficit was the most common presentation. Primary tumors included lung, breast, bladder, myeloma, melanoma, and renal cell cancers. All tumors occurred in the axis vertebra. Preoperative Tokuhashi and Tomita scores ranged from 5 to 13 and 3 to 7, respectively. All patients had undergone occipitocervical fusion of a mean of 4.6 levels (range 2-7 levels). Median survival was 10.3 months. In all cases, neck pain markedly improved and patients were able to resume activities of daily living. The average postoperative pain score was significantly improved as compared with the average preoperative score (1.90 ± 2.56 and 5.50 ± 2.99, respectively, p = 0.01). Three patients experienced postoperative medical complications including urinary tract infection, deep vein thrombosis, myocardial infarction, and cardiac arrhythmia. In the follow-up period, no wound infections or reoperations occurred and no patients experienced spinal cord deficits from tumor recurrence. CONCLUSIONS Posterior-only occipitocervical stabilization was highly effective at relieving patients' neck pain. No instrumentation failures were noted, and no neurological complications or tumor progression causing spinal cord deficits was noted in the follow-up period.

Entities:  

Keywords:  ASA = American Society of Anesthesiologists; ASIA = American Spinal Injury Association; CCJ = craniocervical junction; RT = revised Tokuhashi; SIN = Spinal Instability Neoplastic; VAS = visual analog scale; cervical spine; occipitocervical fusion; oncology; posterior surgery; suboccipital spinal metastases

Mesh:

Year:  2017        PMID: 28291404     DOI: 10.3171/2016.10.SPINE16392

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  4 in total

1.  Posterior occiput-cervical fixation for metastasis to upper cervical spine.

Authors:  Tarush Rustagi; Hazem Mashaly; Ehud Mendel
Journal:  J Craniovertebr Junction Spine       Date:  2019 Apr-Jun

2.  Evaluation of an occipito-cervico fusion with a new implant design: a biomechanical study.

Authors:  Filippo Migliorini; Alice Baroncini; Yasser El Mansy; Valentin Quack; Andreas Prescher; Max Mischer; Johannes Greven; Markus Tingart; Jörg Eschweiler
Journal:  BMC Musculoskelet Disord       Date:  2021-03-06       Impact factor: 2.362

3.  [An application of posterior cervical and transoral approaches to treating primary malignant osseous tumors in craniovertebral junction].

Authors:  Yu Zhang; Fuzhi Ai; Suochao Fu; Keke Li; Hong Xia; Zenghui Wu; Xiangyang Ma
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-09-15

4.  Surgical management of coincidental metastases to upper cervical spine and skull from hepatocellular carcinoma: a case report.

Authors:  Hiroshi Uei; Yasuaki Tokuhashi; Masafumi Maseda; Masahiro Nakahashi; Hirokatsu Sawada; Koji Matsumoto; Yukihiro Miyakata; Hirotoki Soma
Journal:  J Int Med Res       Date:  2018-10-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.